|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EIF4A2-ACTR3 (FusionGDB2 ID:25928) |
Fusion Gene Summary for EIF4A2-ACTR3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EIF4A2-ACTR3 | Fusion gene ID: 25928 | Hgene | Tgene | Gene symbol | EIF4A2 | ACTR3 | Gene ID | 1974 | 10096 |
Gene name | eukaryotic translation initiation factor 4A2 | actin related protein 3 | |
Synonyms | BM-010|DDX2B|EIF4A|EIF4F|eIF-4A-II|eIF4A-II | ARP3 | |
Cytomap | 3q27.3 | 2q14.1 | |
Type of gene | protein-coding | protein-coding | |
Description | eukaryotic initiation factor 4A-IIATP-dependent RNA helicase eIF4A-2 | actin-related protein 3ARP3 actin related protein 3 homologactin-like protein 3 | |
Modification date | 20200322 | 20200327 | |
UniProtAcc | Q14240 | Q9C0K3 | |
Ensembl transtripts involved in fusion gene | ENST00000356531, ENST00000323963, ENST00000440191, | ENST00000263238, ENST00000535589, ENST00000536059, | |
Fusion gene scores | * DoF score | 21 X 21 X 7=3087 | 16 X 13 X 7=1456 |
# samples | 23 | 17 | |
** MAII score | log2(23/3087*10)=-3.74649971667075 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(17/1456*10)=-3.098403704061 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EIF4A2 [Title/Abstract] AND ACTR3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EIF4A2(186502266)-ACTR3(114691856), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EIF4A2 | GO:1900260 | negative regulation of RNA-directed 5'-3' RNA polymerase activity | 11922617 |
Tgene | ACTR3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation | 11741539|17220302 |
Tgene | ACTR3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17220302 |
Fusion gene breakpoints across EIF4A2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ACTR3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-06-0238-01A | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
Top |
Fusion Gene ORF analysis for EIF4A2-ACTR3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000356531 | ENST00000263238 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
5UTR-3CDS | ENST00000356531 | ENST00000535589 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
5UTR-3CDS | ENST00000356531 | ENST00000536059 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000323963 | ENST00000263238 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000323963 | ENST00000535589 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000323963 | ENST00000536059 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000440191 | ENST00000263238 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000440191 | ENST00000535589 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
In-frame | ENST00000440191 | ENST00000536059 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000323963 | EIF4A2 | chr3 | 186502266 | + | ENST00000263238 | ACTR3 | chr2 | 114691856 | + | 6105 | 139 | 64 | 963 | 299 |
ENST00000323963 | EIF4A2 | chr3 | 186502266 | + | ENST00000536059 | ACTR3 | chr2 | 114691856 | + | 1079 | 139 | 64 | 963 | 299 |
ENST00000323963 | EIF4A2 | chr3 | 186502266 | + | ENST00000535589 | ACTR3 | chr2 | 114691856 | + | 1100 | 139 | 64 | 963 | 299 |
ENST00000440191 | EIF4A2 | chr3 | 186502266 | + | ENST00000263238 | ACTR3 | chr2 | 114691856 | + | 6078 | 112 | 34 | 936 | 300 |
ENST00000440191 | EIF4A2 | chr3 | 186502266 | + | ENST00000536059 | ACTR3 | chr2 | 114691856 | + | 1052 | 112 | 34 | 936 | 300 |
ENST00000440191 | EIF4A2 | chr3 | 186502266 | + | ENST00000535589 | ACTR3 | chr2 | 114691856 | + | 1073 | 112 | 34 | 936 | 300 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000323963 | ENST00000263238 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 0.000223842 | 0.9997762 |
ENST00000323963 | ENST00000536059 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 0.00069447 | 0.9993055 |
ENST00000323963 | ENST00000535589 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 0.000700812 | 0.99929917 |
ENST00000440191 | ENST00000263238 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 9.05E-05 | 0.9999094 |
ENST00000440191 | ENST00000536059 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 0.00050234 | 0.99949765 |
ENST00000440191 | ENST00000535589 | EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691856 | + | 0.000506036 | 0.99949396 |
Top |
Fusion Genomic Features for EIF4A2-ACTR3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691855 | + | 0.003534549 | 0.99646544 |
EIF4A2 | chr3 | 186502266 | + | ACTR3 | chr2 | 114691855 | + | 0.003534549 | 0.99646544 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EIF4A2-ACTR3 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:186502266/chr2:114691856) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EIF4A2 | ACTR3 |
FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. | FUNCTION: May play a role in the suppression of metastatic potential in lung adenoma carcinoma cells. {ECO:0000269|PubMed:11162478}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000323963 | + | 2 | 11 | 246_407 | 25 | 408.0 | Domain | Helicase C-terminal |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000323963 | + | 2 | 11 | 64_235 | 25 | 408.0 | Domain | Helicase ATP-binding |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000440191 | + | 2 | 11 | 246_407 | 26 | 409.0 | Domain | Helicase C-terminal |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000440191 | + | 2 | 11 | 64_235 | 26 | 409.0 | Domain | Helicase ATP-binding |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000323963 | + | 2 | 11 | 183_186 | 25 | 408.0 | Motif | Note=DEAD box |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000323963 | + | 2 | 11 | 33_61 | 25 | 408.0 | Motif | Note=Q motif |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000440191 | + | 2 | 11 | 183_186 | 26 | 409.0 | Motif | Note=DEAD box |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000440191 | + | 2 | 11 | 33_61 | 26 | 409.0 | Motif | Note=Q motif |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000323963 | + | 2 | 11 | 77_84 | 25 | 408.0 | Nucleotide binding | ATP |
Hgene | EIF4A2 | chr3:186502266 | chr2:114691856 | ENST00000440191 | + | 2 | 11 | 77_84 | 26 | 409.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for EIF4A2-ACTR3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>25928_25928_1_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000263238_length(transcript)=6105nt_BP=139nt TATAAAAAACGGGTGGTTGGGCGCCGCTGTCTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAA CAGAGAACATGGCGGCCCAGAGGGAATGGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGT AGGAGAACGGACGTTGACCGGTACGGTAATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAG CTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGA ACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGA TGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGG ACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCC TATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGA TTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCAT TACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAA GGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTA GGGAGGTGGGGAAGAGATAATCTTTCTGATTACCTGTTTTGTCTGGATGGCTGGTTTTGAGGTTTTAAACCTGACTTGAAATAGTAACAC CAAACATGATTATACAGGAATATTTTAATAAGTGTATCACCATGCAGATGTAGAAGAGAGCGAAAGTGATTGTGTTTTTCTTTAGATTGA ATATTTGAATCTTATGTGTAACAAAAAGAAGTGGGTTTTAGTTCTTTCTGTGCCCTGATATTTTGTATATTAATGAATTATCCAAGATTC GATGGGATTTATCAGTGTGTAGATAGCTCTATAATGCTTGAATTGTACACTTCTAAGTGTGCAGTGCAAGAGCTTGTTTATATTTCATAC TTTTTATACTTTGAGGAAAAAAAGTCAAAGAAAAATTGTATTTGAGGGAAAAAACCATGACCAAGTAAAGGATAAATTCAAAAAATAGCC TCATGAGACTTGGCATACACACTCGTGGGATTCCAGTTATTATGGAGTGCTTCCATCCCTCTCCACCCCTTCCCCCCAAAAGGTTTTCTT TGCAAGTGCTTTTGGAACTAAGAGCTAGTATCTTGGATTAACTGATGCCTGCTAGTGCTTTCTGATTACTCGCATTCTGTTTCTTGCTTT AAAAGAAGAGTAAAGACAAGAGTGTTGGACCAGTATTGCAGTTCTGTAGTGTCATTTCTTATAAAAAACAAAACAACAACAATAATTTAT CAAAATTGGCATATTTAAAGCCTAACATTCTAATAAAGGCACAAATTTCTTTTTAATACTTGTTTCAGCCTCTTTAATCTCTTTATAAGT TAACTAATAAATCTATTTTCTTCAGACTTCTGCAATAGTTCTTTAAAATCACAACAGTTAGCAAGCTGACTTTTGTAATGTGCTCAATAC AAATACTTGTGAACTTTTAATATGTTGAGTGCTTTCATTTTGATAACTGGATCTCCATTTGATATTTTCATTTGTATAACTCATTTGCAG TCTGAAAATTTTTTTTAGTGCCAGTCCCTGAACATATCATTGAAAGTTAATTTTCTTTGCATTTTAAAATATCTGGATTATGAAGAAAAA GTGATGAAAATAAATTAAAACTGAATTACCTTTTCTAATGTTTTTTTTTTTTAAGTAATGTAATTCTATTTTGTTTTTATGTATGTGATA TCTGTTTCTGTTGAGATTTGGGAGTTATTGAAATCTCTGTAATGTGTATGGTAGAAAATTTCTTGTGACCTTAAAATTTTACCAGTTATT TATAGAAAGAGAAAATGGGAAATGTTTTATAGGCTTTTTACTAGCAGTATCAGTGAACACTTGAACTCCATTATTCATGAAAATAACACG TTAGGATTGGAATACGTCTATTCAAAAGTGAAAGAATATAAAGTGTTTAGTTTTTTGTTTTTACTCTAAAGATAGAATTGGGGAGTAAAC TTCAGTTTTTGTTTAGAGTGGATCTGAATATTTAAAATCCTATAATAATTTTTGTGAATCTTCATTCTTTGAGTATGGGATTGTAAAAGA CAAACTATATCCTACAGTAGTATCATCATCAGTATCAAAGGTCTCCTTTTTTTACTTGGAAAAGTAATTCACAAACATTATAAAAATACT ATTCAAACAGTACCAAAGAGTAGATTAGCAAAAGTAAGTTTTTTTCCCTAGCCTGTCTCATTTTTCCATCATTACACAGACTACTTGGAA TGTCTTAGATGTCCTTGTATTGTAATTTTCTGTGTAGGTAGAAATAAATGTAGCTTTCTTATTTTACACAAATAGGAACTTACTGTATAT ACTGTTCTGCACTTTGCTTTTATTAAAGATCTTTTGATAAAGAACTATATTGATAAGCAGTAAAGATGTCATGCTCCTGGCCCAATAAAA TATTGTTAGCATTGTCATAAATATGTCTTTTCCACCGGCGATGGTTGGGTAGTTAAGTGAATAAGCTAGAAAGACATGTTTATAAAGCTA TTTGATGACAATCTCAGGCATATTTATACAGAGATGTTCTTAACTGTTTGCTACAAAAACATGAAGATCAAAAACTTTCTTGAAGCTTAC GCTTAACTTATTTGGGGAAACAAAACTCCAGCCCTTCTTGTGTATGTTCTGATATCCCTTTGCTCTACTTTTAGAGGAGTGAACCCTAAT AGGATGGTAGCAGCATTCTTGTTTCTTTATATCTCTCCTCTGTGATTGTATACCGTTTTTTCAACTTAAAGCAACTTCAGCTGGAAATAT GTAGAGGTTGGCCAAGGTGAACTAAATAGTCTGTAACATTGATTAGATATCAAGCAACGTGAGCATGGTAGCAAAAGCACTAACTGAAGC CAGTGATTTAATTTTTAATTCTGATTCTGATAATTGATGATATAGCTCCTCGAACTTTGTTTTTTGTTAAAACTTGGAAAATATATTTGT ATTATTTTGGACAAATTATTTGAACTCTCTGGACCTTGATTCAATTTATATATAAGGTAAAGGCATTATACTGGATTATCCTGCAATTTC TTTGAGTTGTTAGAATATAATGTAGCTTATTAATAGCAATATTAGCAGTGTAGTAGATTCTGACTGCAAAACCTAGCCTTTTCTATTGAT TCATTAGTGGTAGTAAAGGTATTATCTGATTTATCCTTTTTAATAGGCAGTGCTTTGATCAAGTGGGAAATAGTAATGGACAAATAAAAT CAATGATCATTATCTAACTTGATGCCTGCTTTTCAAAAAGTGAGCAAATTTCACATCTTCACCCTTAGACATTAATTCATGGCACCTACT ATAAGTACTCATCCTCTTCTTACCTATCTTCTTTTCTATAGGAGATAAAGTGGTTATTCAGACCCCCCAATACAATTTTTTGGTTTGTTT TCACAGCTACTTAAAAGATTAAAATAACTATTCTTGCAGATATTTCTAGGAATATTTTTAGAAATAATATGAAATACAGGGATAATAGGC CAATTATGATCTTTATTTTTAATTTCTACAGAAAAGTACTAGAGAATATATCTATAGAAACTTCTTTCAGATAACCCTAAAGATGATACT AGAATGTTTATAAAATTATTGAGAAGATTATTTGTGTTATAAAGCTTATTTGTACCATAGTAAAGGATGTTTTTGTTCCTCTTCATTCTG GGCTAATCTGTCAATACTGAAGTCCAGTCTTTTCCCCCTTTTCTTACCAGCTCAACCTTGATTCCTGTGACCCATTCTTTCTGATCTTTC GTAGTTCATAGTCACCAGGCATGAGTACCTTGGATAGCCCTCTGAAGTCTGTTACCACCCAGATTTCCAACTCGGGTTAATTGGTACTAA TTCTATTAGCTGGTATAAATAATCCAAAATCTGTGCAGACTCTGGGAGCAAAATGTTCTACTCAGTTTGGAATACTGTGCCTTAAAATAT ATTTCATTGTAACAGCACCTTGTATATATAGTTGGCCAAGGACAGAGTTGTTACAAGTTACGTGGAACTTTCATAGCAAATCTTGACAGT AAATACCTTGTTCTTGTATTAGGTCTATATCCTGAATTGACCTTTAGCAAGAATCTTTAGATCTGCTGGAGGGCTGGGATGGCTTTTGGA CTTCAGTGAAAAAGAATTTCTGCTACTCATTGTTGATAACGCTTCAGTACTGTATAAATGTTTATCCTTTTCCACGTAATTTGTTTTCTA TGATATGAGAACTTTTATTATAATTTGCCTCAGTCTTGATAGAATCTTAACAAAAATAAAATCTGTGGTCGTCTGAGGTATTCTCCATGC TATAACCCAGTTTAGCTGATGCATTTGGAGCTTGGGTGCTGAAATTAAATATAACCTATTTGAGTTAAGGATTTATTACTAGTGCTCCAG TGGTCACAGGAACAATAAAAAAGGAACAACGATAGAAATACGTGATCTAGGAAAGAAGGCAACTGAAAAACCTGAAAGAAAAAAAATGAA AGATTAAAAGTATACGATATTCTATTTTGATTTAGCAATTACTTGTTTTCTAGTGTTCTGTCAATTTTTGGTGACTTTTATAATTACATT AAAACTAAGATGCTGAATTAAAATAAAGTTTCTCTTTTATTCAAGCACCAACATTCACTTATATTACCTATATATTGCATCAAGTTTTGA GCCTTCAATCCCAGAAGCATTGATTGACTGTCTACTGTGGTTCAAGTACTGTGCATAAAGATGAATAAATATTCTGTCCTTGGCTTAGTC TAATAGTAAAGGCACTCTTAGAGGAGGGACAAATATTTTGCCTAGATAAGATTTGAGAGATAGTAAGTGCGGAATTTCTCTTCATAAAAA TGGTAGTGTTAGTTGTTTAGAGGGAGAAGTCCAGCTATGTAAGGTGAAAGTGGGGCTTATAAAAGTGGATCTATTGTTTAAAAATTAGTA CTTTGCTCCTAAAATTTTTACCTAAGTGTTACATCCAACAACAGATGAAAGTAATTCGACAGTAGCATCTGCTTTATTCATTTCATATTT CCAGTGCCTGACATATTGCTTGGCATATAGTAGTTTAGTGGATGTGTTTGATGAATGAATGAGTAAAAATTATTTTTCATGTTAAAATAA AACTTTGAATTACATGAGTATACAACTTTTGTTCCTTCAAAATACCCATATTTGTCAAATATGACCGAATTACGACTTTTTTTCTGTTCC ACTAGTTTCTACCTTAGAAGTGACATTCTGCGTAAGGTAGTGGGGGATTACTAAGTGATCATGACTTTTCTGAAGCAGGTCTTAAATAAT TATCTAAGCCTTCAGTCATTTCAAAATCTCTGTAGTGTAAATGATCACAGGCTCTAAATCAGATTGTTGTACAAGGTAATTGACATGTCC TGAAATGTAACATTCAACATTAACAGTAGAAACAGGCCTCATTTCTCCCTCTGGCTTTTATTGATCAATTTTGATATTGTCCAGATCCCA TGTTAAACCACTTGATTTAGAGATGACTTAATTCTAAACTTCCTCCATTTTTAATTAATAAGATTCAAGGTTGCAGTAAATTGTTAATCT >25928_25928_1_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000263238_length(amino acids)=299AA_BP=25 MSGGSADYNREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLR DREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEV VDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPE -------------------------------------------------------------- >25928_25928_2_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000535589_length(transcript)=1100nt_BP=139nt TATAAAAAACGGGTGGTTGGGCGCCGCTGTCTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAA CAGAGAACATGGCGGCCCAGAGGGAATGGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGT AGGAGAACGGACGTTGACCGGTACGGTAATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAG CTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGA ACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGA TGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGG ACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCC TATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGA TTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCAT TACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAA GGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTA GGGAGGTGGGGAAGAGATAATCTTTCTGATTACCTGTTTTGTCTGGATGGCTGGTTTTGAGGTTTTAAACCTGACTTGAAATAGTAACAC >25928_25928_2_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000535589_length(amino acids)=299AA_BP=25 MSGGSADYNREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLR DREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEV VDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPE -------------------------------------------------------------- >25928_25928_3_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000536059_length(transcript)=1079nt_BP=139nt TATAAAAAACGGGTGGTTGGGCGCCGCTGTCTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAA CAGAGAACATGGCGGCCCAGAGGGAATGGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGT AGGAGAACGGACGTTGACCGGTACGGTAATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAG CTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGA ACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGA TGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGG ACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCC TATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGA TTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCAT TACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAA GGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTA >25928_25928_3_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000323963_ACTR3_chr2_114691856_ENST00000536059_length(amino acids)=299AA_BP=25 MSGGSADYNREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLR DREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEV VDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPE -------------------------------------------------------------- >25928_25928_4_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000263238_length(transcript)=6078nt_BP=112nt CTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAACAGCAGAGAACATGGCGGCCCAGAGGGAAT GGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGTAGGAGAACGGACGTTGACCGGTACGGT AATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGG ACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGT AAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATAC TGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTT TGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAA GAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCT GAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGT TTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCAT TTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCT GATTACCTGTTTTGTCTGGATGGCTGGTTTTGAGGTTTTAAACCTGACTTGAAATAGTAACACCAAACATGATTATACAGGAATATTTTA ATAAGTGTATCACCATGCAGATGTAGAAGAGAGCGAAAGTGATTGTGTTTTTCTTTAGATTGAATATTTGAATCTTATGTGTAACAAAAA GAAGTGGGTTTTAGTTCTTTCTGTGCCCTGATATTTTGTATATTAATGAATTATCCAAGATTCGATGGGATTTATCAGTGTGTAGATAGC TCTATAATGCTTGAATTGTACACTTCTAAGTGTGCAGTGCAAGAGCTTGTTTATATTTCATACTTTTTATACTTTGAGGAAAAAAAGTCA AAGAAAAATTGTATTTGAGGGAAAAAACCATGACCAAGTAAAGGATAAATTCAAAAAATAGCCTCATGAGACTTGGCATACACACTCGTG GGATTCCAGTTATTATGGAGTGCTTCCATCCCTCTCCACCCCTTCCCCCCAAAAGGTTTTCTTTGCAAGTGCTTTTGGAACTAAGAGCTA GTATCTTGGATTAACTGATGCCTGCTAGTGCTTTCTGATTACTCGCATTCTGTTTCTTGCTTTAAAAGAAGAGTAAAGACAAGAGTGTTG GACCAGTATTGCAGTTCTGTAGTGTCATTTCTTATAAAAAACAAAACAACAACAATAATTTATCAAAATTGGCATATTTAAAGCCTAACA TTCTAATAAAGGCACAAATTTCTTTTTAATACTTGTTTCAGCCTCTTTAATCTCTTTATAAGTTAACTAATAAATCTATTTTCTTCAGAC TTCTGCAATAGTTCTTTAAAATCACAACAGTTAGCAAGCTGACTTTTGTAATGTGCTCAATACAAATACTTGTGAACTTTTAATATGTTG AGTGCTTTCATTTTGATAACTGGATCTCCATTTGATATTTTCATTTGTATAACTCATTTGCAGTCTGAAAATTTTTTTTAGTGCCAGTCC CTGAACATATCATTGAAAGTTAATTTTCTTTGCATTTTAAAATATCTGGATTATGAAGAAAAAGTGATGAAAATAAATTAAAACTGAATT ACCTTTTCTAATGTTTTTTTTTTTTAAGTAATGTAATTCTATTTTGTTTTTATGTATGTGATATCTGTTTCTGTTGAGATTTGGGAGTTA TTGAAATCTCTGTAATGTGTATGGTAGAAAATTTCTTGTGACCTTAAAATTTTACCAGTTATTTATAGAAAGAGAAAATGGGAAATGTTT TATAGGCTTTTTACTAGCAGTATCAGTGAACACTTGAACTCCATTATTCATGAAAATAACACGTTAGGATTGGAATACGTCTATTCAAAA GTGAAAGAATATAAAGTGTTTAGTTTTTTGTTTTTACTCTAAAGATAGAATTGGGGAGTAAACTTCAGTTTTTGTTTAGAGTGGATCTGA ATATTTAAAATCCTATAATAATTTTTGTGAATCTTCATTCTTTGAGTATGGGATTGTAAAAGACAAACTATATCCTACAGTAGTATCATC ATCAGTATCAAAGGTCTCCTTTTTTTACTTGGAAAAGTAATTCACAAACATTATAAAAATACTATTCAAACAGTACCAAAGAGTAGATTA GCAAAAGTAAGTTTTTTTCCCTAGCCTGTCTCATTTTTCCATCATTACACAGACTACTTGGAATGTCTTAGATGTCCTTGTATTGTAATT TTCTGTGTAGGTAGAAATAAATGTAGCTTTCTTATTTTACACAAATAGGAACTTACTGTATATACTGTTCTGCACTTTGCTTTTATTAAA GATCTTTTGATAAAGAACTATATTGATAAGCAGTAAAGATGTCATGCTCCTGGCCCAATAAAATATTGTTAGCATTGTCATAAATATGTC TTTTCCACCGGCGATGGTTGGGTAGTTAAGTGAATAAGCTAGAAAGACATGTTTATAAAGCTATTTGATGACAATCTCAGGCATATTTAT ACAGAGATGTTCTTAACTGTTTGCTACAAAAACATGAAGATCAAAAACTTTCTTGAAGCTTACGCTTAACTTATTTGGGGAAACAAAACT CCAGCCCTTCTTGTGTATGTTCTGATATCCCTTTGCTCTACTTTTAGAGGAGTGAACCCTAATAGGATGGTAGCAGCATTCTTGTTTCTT TATATCTCTCCTCTGTGATTGTATACCGTTTTTTCAACTTAAAGCAACTTCAGCTGGAAATATGTAGAGGTTGGCCAAGGTGAACTAAAT AGTCTGTAACATTGATTAGATATCAAGCAACGTGAGCATGGTAGCAAAAGCACTAACTGAAGCCAGTGATTTAATTTTTAATTCTGATTC TGATAATTGATGATATAGCTCCTCGAACTTTGTTTTTTGTTAAAACTTGGAAAATATATTTGTATTATTTTGGACAAATTATTTGAACTC TCTGGACCTTGATTCAATTTATATATAAGGTAAAGGCATTATACTGGATTATCCTGCAATTTCTTTGAGTTGTTAGAATATAATGTAGCT TATTAATAGCAATATTAGCAGTGTAGTAGATTCTGACTGCAAAACCTAGCCTTTTCTATTGATTCATTAGTGGTAGTAAAGGTATTATCT GATTTATCCTTTTTAATAGGCAGTGCTTTGATCAAGTGGGAAATAGTAATGGACAAATAAAATCAATGATCATTATCTAACTTGATGCCT GCTTTTCAAAAAGTGAGCAAATTTCACATCTTCACCCTTAGACATTAATTCATGGCACCTACTATAAGTACTCATCCTCTTCTTACCTAT CTTCTTTTCTATAGGAGATAAAGTGGTTATTCAGACCCCCCAATACAATTTTTTGGTTTGTTTTCACAGCTACTTAAAAGATTAAAATAA CTATTCTTGCAGATATTTCTAGGAATATTTTTAGAAATAATATGAAATACAGGGATAATAGGCCAATTATGATCTTTATTTTTAATTTCT ACAGAAAAGTACTAGAGAATATATCTATAGAAACTTCTTTCAGATAACCCTAAAGATGATACTAGAATGTTTATAAAATTATTGAGAAGA TTATTTGTGTTATAAAGCTTATTTGTACCATAGTAAAGGATGTTTTTGTTCCTCTTCATTCTGGGCTAATCTGTCAATACTGAAGTCCAG TCTTTTCCCCCTTTTCTTACCAGCTCAACCTTGATTCCTGTGACCCATTCTTTCTGATCTTTCGTAGTTCATAGTCACCAGGCATGAGTA CCTTGGATAGCCCTCTGAAGTCTGTTACCACCCAGATTTCCAACTCGGGTTAATTGGTACTAATTCTATTAGCTGGTATAAATAATCCAA AATCTGTGCAGACTCTGGGAGCAAAATGTTCTACTCAGTTTGGAATACTGTGCCTTAAAATATATTTCATTGTAACAGCACCTTGTATAT ATAGTTGGCCAAGGACAGAGTTGTTACAAGTTACGTGGAACTTTCATAGCAAATCTTGACAGTAAATACCTTGTTCTTGTATTAGGTCTA TATCCTGAATTGACCTTTAGCAAGAATCTTTAGATCTGCTGGAGGGCTGGGATGGCTTTTGGACTTCAGTGAAAAAGAATTTCTGCTACT CATTGTTGATAACGCTTCAGTACTGTATAAATGTTTATCCTTTTCCACGTAATTTGTTTTCTATGATATGAGAACTTTTATTATAATTTG CCTCAGTCTTGATAGAATCTTAACAAAAATAAAATCTGTGGTCGTCTGAGGTATTCTCCATGCTATAACCCAGTTTAGCTGATGCATTTG GAGCTTGGGTGCTGAAATTAAATATAACCTATTTGAGTTAAGGATTTATTACTAGTGCTCCAGTGGTCACAGGAACAATAAAAAAGGAAC AACGATAGAAATACGTGATCTAGGAAAGAAGGCAACTGAAAAACCTGAAAGAAAAAAAATGAAAGATTAAAAGTATACGATATTCTATTT TGATTTAGCAATTACTTGTTTTCTAGTGTTCTGTCAATTTTTGGTGACTTTTATAATTACATTAAAACTAAGATGCTGAATTAAAATAAA GTTTCTCTTTTATTCAAGCACCAACATTCACTTATATTACCTATATATTGCATCAAGTTTTGAGCCTTCAATCCCAGAAGCATTGATTGA CTGTCTACTGTGGTTCAAGTACTGTGCATAAAGATGAATAAATATTCTGTCCTTGGCTTAGTCTAATAGTAAAGGCACTCTTAGAGGAGG GACAAATATTTTGCCTAGATAAGATTTGAGAGATAGTAAGTGCGGAATTTCTCTTCATAAAAATGGTAGTGTTAGTTGTTTAGAGGGAGA AGTCCAGCTATGTAAGGTGAAAGTGGGGCTTATAAAAGTGGATCTATTGTTTAAAAATTAGTACTTTGCTCCTAAAATTTTTACCTAAGT GTTACATCCAACAACAGATGAAAGTAATTCGACAGTAGCATCTGCTTTATTCATTTCATATTTCCAGTGCCTGACATATTGCTTGGCATA TAGTAGTTTAGTGGATGTGTTTGATGAATGAATGAGTAAAAATTATTTTTCATGTTAAAATAAAACTTTGAATTACATGAGTATACAACT TTTGTTCCTTCAAAATACCCATATTTGTCAAATATGACCGAATTACGACTTTTTTTCTGTTCCACTAGTTTCTACCTTAGAAGTGACATT CTGCGTAAGGTAGTGGGGGATTACTAAGTGATCATGACTTTTCTGAAGCAGGTCTTAAATAATTATCTAAGCCTTCAGTCATTTCAAAAT CTCTGTAGTGTAAATGATCACAGGCTCTAAATCAGATTGTTGTACAAGGTAATTGACATGTCCTGAAATGTAACATTCAACATTAACAGT AGAAACAGGCCTCATTTCTCCCTCTGGCTTTTATTGATCAATTTTGATATTGTCCAGATCCCATGTTAAACCACTTGATTTAGAGATGAC TTAATTCTAAACTTCCTCCATTTTTAATTAATAAGATTCAAGGTTGCAGTAAATTGTTAATCTTATTTGGAATTATATTAGAAAGTCGAT >25928_25928_4_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000263238_length(amino acids)=300AA_BP=26 MSGGSADYNSREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLL RDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISE VVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTP -------------------------------------------------------------- >25928_25928_5_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000535589_length(transcript)=1073nt_BP=112nt CTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAACAGCAGAGAACATGGCGGCCCAGAGGGAAT GGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGTAGGAGAACGGACGTTGACCGGTACGGT AATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGG ACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGT AAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATAC TGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTT TGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAA GAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCT GAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGT TTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCAT TTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCT >25928_25928_5_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000535589_length(amino acids)=300AA_BP=26 MSGGSADYNSREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLL RDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISE VVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTP -------------------------------------------------------------- >25928_25928_6_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000536059_length(transcript)=1052nt_BP=112nt CTTTTCAGTCGGGCGCTGAGTGGTTTTTCGGATCATGTCTGGTGGCTCCGCGGATTATAACAGCAGAGAACATGGCGGCCCAGAGGGAAT GGACCCCGATGGTGTCATCGAGGCTGTTCTTGCCTTAGCTGCATCTTGGACCTCAAGACAAGTAGGAGAACGGACGTTGACCGGTACGGT AATAGACAGTGGAGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGG ACGAGATATAACATATTTTATTCAGCAACTGCTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGT AAAGGAGCGCTATAGTTATGTCTGCCCAGATTTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATAC TGGAATCAATGCTATCTCAAAGAAAGAGTTTTCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTT TGCTAATCCAGACTTTACACAACCTATCTCAGAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAA GAATATTGTCCTCTCTGGAGGTTCAACCATGTTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCT GAAATTAAGTGAGGAATTGAGTGGTGGTAGATTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGT TTGGTTTGGAGGATCAATGCTGGCTTCCACGCCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCAT TTGTCGTCACAATCCAGTGTTTGGAGTCATGTCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCT >25928_25928_6_EIF4A2-ACTR3_EIF4A2_chr3_186502266_ENST00000440191_ACTR3_chr2_114691856_ENST00000536059_length(amino acids)=300AA_BP=26 MSGGSADYNSREHGGPEGMDPDGVIEAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLL RDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISE VVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EIF4A2-ACTR3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF4A2-ACTR3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF4A2-ACTR3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |